
Opinion|Videos|February 24, 2025
New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast
Panelists discuss the topical treatment option roflumilast for pediatric atopic dermatitis, exploring its mechanism of action, efficacy, safety, and potential role in managing the condition.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Now let’s talk about some of the latest treatment advances in pediatric atopic dermatitis, starting with topicals. Discuss the topical treatment options that are newly available or on the horizon, including how they work to treat atopic dermatitis as well as efficacy and safety:
- Roflumilast
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5





















